Closed tender
Managed Service contract for Molecular Pathology Testing
Details
- Published
- 22 November 2022
- Submission
- 12 April 2019
- Source
- uk:bravosolution
Tender description
The University Hospitals Birmingham NHS Foundation Trust is looking to implement a managed service contract for Molecular Pathology Testing, this will include Molecular Screening for EGFR, BRAF, KRAS and NRAS mutations
Timeline
- Completed: Submission date12 April 2019
- Completed: Tender published22 November 2022Current notice
About the buyer
University Hospitals Birmingham NHS Foundation Trust is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@university-hospitals-birmingham-nhs-foundation-trust.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@university-hospitals-birmingham-nhs-foundation-trust.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@university-hospitals-birmingham-nhs-foundation-trust.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@university-hospitals-birmingham-nhs-foundation-trust.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@university-hospitals-birmingham-nhs-foundation-trust.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@university-hospitals-birmingham-nhs-foundation-trust.gov |
Related buyers
Buyers similar to University Hospitals Birmingham NHS Foundation Trust.
BuyersCountValue
- 496£237.5m
- 371£5.3bn
- 251£44.8m
- 219£16.4m
- 219£225.1m
- 210£11.7m
- 206£130.7m
- 169£11.1bn
- 167£96.6m
- 167£45.0m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
